Opportunities in Japan Pharma & Medical Device Market Entry

Watch our free webinar to learn about some of the regulatory challenges and market entry options as you consider your strategy for the Japan market.

Different Market Entry Options Available to UK Life Science and Pharma Companies in Japan

Background to the Webinar

The revised law for regulating pharmaceuticals, medical devices and regenerative medicine products – the “Pharmaceutical and Medical Devices Act” – was enforced in November 2014 and Japan has reduced regulatory timelines and introduced a number of favourable initiatives for fast-tracking and premium price acquisition. Now may be the best time ever to enter the Japanese market. However, new entrants should be aware of the regulatory challenges and market entry options to consider their strategy for the Japan market.

In this webinar, Mr Rob Claar from Vorpal Technologies K.K. will talk about the best practices and pitfalls when seeking regulatory approval, pricing reimbursement, and things to be aware of for foreign companies wishing to enter the market. He will also cover commercialisation through a traditional distributor mode, direct entry, or a more creative and transparent commercial solution.

About Vorpal Technologies

Vorpal is a fully-integrated solution provider for Japan healthcare market entry, with services including opportunity validation, clinical development, regulatory affairs, market access, business incubation, representation (D-MAH), QA and logistics services. Vorpal is a virtual subsidiary in Japan for dozens of overseas healthcare companies.

About the Speaker

Rob Claar is co-founder and CEO of Vorpal Technologies, prior to which he was co-founder and CEO of Juniper Consulting Group, a global healthcare market research and strategy consultancy. Rob graduated from Yale University and later joined a Tokyo based consulting firm’s healthcare practice. Rob has 25 years’ experience in global healthcare innovation management, opportunity assessment, strategy development, clinical and regulatory affairs, reimbursement and commercialisation.

How will UK companies benefit from watching?

This webinar will provide practical advice and describe case studies in Japan healthcare market entry that are relevant to small and medium-sized pharma and device companies considering a Japan market strategy.

The PowerPoint slides are available below.

This webinar was recorded on 22 January 2016.

Send us your enquiry to find out your potential of doing business in Japan.

Check out our dedicated life sciences page for the latest news and articles.

Japan Healthcare Market Entry Opportunity & Challenges